🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › Michigan › Norton Shores

Non-Small Cell Lung Cancer clinical trials in Norton Shores, MI

5 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Norton Shores (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RecruitingPhase 3
  • Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

RecruitingPhase 3
  • Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06498635

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

RecruitingPhase 1
  • Cancer and Hematology Centers of Western Michigan, Norton Shores
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05245500

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

RecruitingPhase 2
  • Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06116682

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RecruitingObservational study
  • Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores
Ages 18 and older · All sexes · Updated Mar 17, 2026 · NCT06418204

Non-Small Cell Lung Cancer trials in other cities

Other studies in Norton Shores

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.